Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of apremilast (CC-10004) in Japanese patients with palmoplantar pustulosis; the study completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Palmoplantaris Pustulosis | Phase 2 | Status: COMPLETED | Results posted: 2022-01-06